Sunday, February 26, 2006

 

oseltamivir

Correspondence
PreviousPrevious
Volume 354:879-880 February 23, 2006 Number 8
NextNext

Probenecid with Oseltamivir for Human Influenza A (H5N1) Virus Infection?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.



This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Find Similar Articles
-PubMed Citation
To the Editor: Probenecid is an inexpensive medication that was widely used when penicillin was in short supply. Owing to the current easy access to abundant supplies of penicillin, this approach is primarily of historical interest. In light of the limited supply of oseltamivir, however, it may be time to revisit the use of probenecid as adjunctive therapy for human influenza A (H5N1) virus infection. Coadministration of oseltamivir and probenecid has resulted in a reduction in the clearance of oseltamivir by approximately 50 percent and a corresponding doubling of the plasma levels of oseltamivir.1 Therefore, part of the planning . . . [Full Text of this Article]


Comments: Post a Comment



<< Home

This page is powered by Blogger. Isn't yours?